DVADaVita Inc.

DVA Stock Price, Valuation & Chart | DaVita Inc.

Compare

$179.39+3.25 (+1.85%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Medical - Care Facilities DVA intrinsic value DVA calculated fair value vs price

Overview Financials Dividends Ratios

DVA Historical price chart

DVA Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization11.52B

PE Ratio14.01

EPS12.8

Trading Volume513.09K

Today's High/Low179.85/176.43

Dividend Yield0.00

52 Week High/Low247.49/101.0

Shares Outstanding64.20M

DVA Financial Statement

DVA Analyst ratings

DVA Analysis & performance metrics

DVA Company profile

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab…

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other…

DVA Management team

Name

Position

Kathleen Alyce Waters

Chief Legal & Public Affairs Officer

James O. Hearty

Chief Compliance Officer

Misha Palecek

Chief Transformation Officer of U.S. Kidney Care Business

Javier J. RodriguezCEO

Chief Executive Officer & Executive Director

Joel AckermanCFO

Chief Financial Officer & Treasurer

David P. MaughanCOO

Chief Operating Officer of Kidney Care

Christopher Michael Berry CPA

Group Vice President & Chief Accounting Officer

Nic Eliason

Group Vice President of Investor Relations

Name

Position

Kathleen Alyce Waters

Chief Legal & Public Affairs Officer

James O. Hearty

Chief Compliance Officer

Misha Palecek

Chief Transformation Officer of U.S. Kidney Care Business

Javier J. RodriguezCEO

Chief Executive Officer & Executive Director

Joel AckermanCFO

Chief Financial Officer & Treasurer

David P. MaughanCOO

Chief Operating Officer of Kidney Care

Christopher Michael Berry CPA

Group Vice President & Chief Accounting Officer

Nic Eliason

Group Vice President of Investor Relations

Management Team

Kathleen Alyce Waters

Chief Legal & Public Affairs Officer

James O. Hearty

Chief Compliance Officer

Misha Palecek

Chief Transformation Officer of U.S. Kidney Care Business

Javier J. RodriguezCEO

Chief Executive Officer & Executive Director

Joel AckermanCFO

Chief Financial Officer & Treasurer

David P. MaughanCOO

Chief Operating Officer of Kidney Care

Christopher Michael Berry CPA

Group Vice President & Chief Accounting Officer

Nic Eliason

Group Vice President of Investor Relations

Management

Kathleen Alyce Waters

Chief Legal & Public Affairs Officer

James O. Hearty

Chief Compliance Officer

Misha Palecek

Chief Transformation Officer of U.S. Kidney Care Business

Javier J. RodriguezCEO

Chief Executive Officer & Executive Director

Joel AckermanCFO

Chief Financial Officer & Treasurer

David P. MaughanCOO

Chief Operating Officer of Kidney Care

Christopher Michael Berry CPA

Group Vice President & Chief Accounting Officer

Nic Eliason

Group Vice President of Investor Relations

Total 8 executives

DVA Frequently asked questions

What is DaVita Inc. (DVA) Stock Price?

Current stock price of DaVita Inc. (DVA) stock is $179.39. The stock price is +1.85% higher in the session. The intraday range can be seen from this page. Volume of DaVita Inc. (DVA) stock is 513.09K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the DaVita Inc. (DVA) stock price going up or down today?

The stock price of DaVita Inc. (DVA) can change with earnings, company news, and overall market sentiment. DaVita Inc. operates in the Healthcare / Medical - Care Facilities market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the DaVita Inc. stock expensive at its current price?

Whether DaVita Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for DVA on this page is 14.01. EPS on this page is 12.80. Compare those figures with peers and growth expectations before deciding if the current DaVita Inc. price is justified.

How has the stock price of DaVita Inc. (DVA) performed historically?

Historical performance for DaVita Inc. (DVA) is shown on the price chart on this page. Review multi-period moves alongside volume to see how DVA reacted to past earnings and market events.

Should I buy DaVita Inc. (DVA) stock, at this price?

Buying DaVita Inc. (DVA) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.